|
Myeloid Neoplasia
Citations 141-150 of 176 total displayed.
|
Past content
(since Jan 2009):
|
Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia
- Dong Hwan (Dennis) Kim, Wei Xu, Clement Ma, Xiangdong Liu, Katherine Siminovitch, Hans A. Messner, and Jeffrey H. Lipton
Blood 2009; 113: 2517-2525.
[Abstract]
[Full text]
[PDF]
Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity
- Christine M. Hartford, Shiwei Duan, Shannon M. Delaney, Shuangli Mi, Emily O. Kistner, Jatinder K. Lamba, R. Stephanie Huang, and M. Eileen Dolan
Blood 2009; 113: 2145-2153.
[Abstract]
[Full text]
[PDF]
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy
- Elias Jabbour, Hagop M. Kantarjian, Dan Jones, Jenny Shan, Susan O'Brien, Neeli Reddy, William G. Wierda, Stefan Faderl, Guillermo Garcia-Manero, Srdan Verstovsek, Mary Beth Rios, and Jorge Cortes
Blood 2009; 113: 2154-2160.
[Abstract]
[Full text]
[PDF]
High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow
- J. Joseph Melenhorst, Phillip Scheinberg, Pratip K. Chattopadhyay, Emma Gostick, Kristin Ladell, Mario Roederer, Nancy F. Hensel, Daniel C. Douek, A. John Barrett, and David A. Price
Blood 2009; 113: 2238-2244.
[Abstract]
[Full text]
[PDF]
Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
- Katayoun Rezvani, Agnes S. M. Yong, Abdul Tawab, Behnam Jafarpour, Rhoda Eniafe, Stephan Mielke, Bipin N. Savani, Keyvan Keyvanfar, Yixin Li, Roger Kurlander, and A. John Barrett
Blood 2009; 113: 2245-2255.
[Abstract]
[Full text]
[PDF]
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
- Miguel A. Sanz, David Grimwade, Martin S. Tallman, Bob Lowenberg, Pierre Fenaux, Elihu H. Estey, Tomoki Naoe, Eva Lengfelder, Thomas Büchner, Hartmut Döhner, Alan K. Burnett, and Francesco Lo-Coco
Blood 2009; 113: 1875-1891.
[Abstract]
[Full text]
[PDF]
Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system
- Olga K. Weinberg, Mahesh Seetharam, Li Ren, Katie Seo, Lisa Ma, Jason D. Merker, Jason Gotlib, James L. Zehnder, and Daniel A. Arber
Blood 2009; 113: 1906-1908.
[Abstract]
[Full text]
[PDF]
Hematopoietic defects in the Ts1Cje mouse model of Down syndrome
- Catherine L. Carmichael, Ian J. Majewski, Warren S. Alexander, Donald Metcalf, Douglas J. Hilton, Chelsee A. Hewitt, and Hamish S. Scott
Blood 2009; 113: 1929-1937.
[Abstract]
[Full text]
[PDF]
Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F
- Franz X. Schaub, Roland Jäger, Renate Looser, Hui Hao-Shen, Sylvie Hermouet, François Girodon, Andre Tichelli, Heinz Gisslinger, Robert Kralovics, and Radek C. Skoda
Blood 2009; 113: 2022-2027.
[Abstract]
[Full text]
[PDF]
High-affinity neurotrophin receptors and ligands promote leukemogenesis
- Zhixiong Li, Gernot Beutel, Mathias Rhein, Johann Meyer, Christian Koenecke, Thomas Neumann, Min Yang, Jürgen Krauter, Nils von Neuhoff, Michael Heuser, Helmut Diedrich, Gudrun Göhring, Ludwig Wilkens, Brigitte Schlegelberger, Arnold Ganser, and Christopher Baum
Blood 2009; 113: 2028-2037.
[Abstract]
[Full text]
[PDF]
|
|
